PubRank
Search
About
S Loukides
Author PubWeight™ 23.92
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Exhaled breath condensate: methodological recommendations and unresolved questions.
Eur Respir J
2005
5.24
2
Exhaled nitric oxide in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
1998
1.60
3
Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
Eur J Clin Invest
2006
1.04
4
Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis.
Thorax
1998
1.04
5
Exhaled breath condensate in patients with asthma: implications for application in clinical practice.
Clin Exp Allergy
2008
1.01
6
Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.
Thorax
1998
0.99
7
Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia.
Thorax
2003
0.95
8
Total nitrite/nitrate in expired breath condensate of patients with asthma.
Respir Med
2001
0.94
9
Exhaled nitric oxide is increased in active fibrosing alveolitis.
Chest
1999
0.93
10
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.
Ann Oncol
2004
0.90
11
The prevalence of congenital bronchial atresia in males.
Monaldi Arch Chest Dis
2004
0.86
12
Evaluation of nasal patency: comparison of patient and clinician assessments with rhinomanometry.
Acta Otolaryngol
1998
0.83
13
Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma.
Allergy
2012
0.83
14
Effect of arginine on mucociliary function in primary ciliary dyskinesia.
Lancet
1998
0.82
15
Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients.
PLoS One
2012
0.81
16
Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit.
Respir Med
2006
0.80
17
Magnesium levels in plasma and erythrocytes before and after histamine challenge.
Eur Respir J
2000
0.79
18
Prostaglandin E2 in the expired breath condensate of patients with asthma.
Eur Respir J
2003
0.77
19
Sputum interleukin-13 as a biomarker for the evaluation of asthma control.
Clin Exp Allergy
2016
0.76
20
Levels of prostaglandin E(2) and Cysteinyl-leukotrienes in sputum supernatant of patients with asthma: the effect of smoking.
Clin Exp Allergy
2013
0.75
21
Bilateral pleural effusions associated with pravastatin sodium treatment.
Eur Respir J
2007
0.75
22
The usefulness of inflammatory markers in monitoring treatment responses in asthma.
Clin Exp Allergy
2003
0.75
23
Exhaled nitric oxide as screening tool in subjects with suspected asthma without reversibility.
Int Arch Allergy Immunol
2013
0.75
24
Simultaneous pulmonary and intrathoracic lymph nodal granulomatosis of unknown significance (GLUS).
Monaldi Arch Chest Dis
2004
0.75
25
Cytokine production by monocytes/macrophages is normal in patients with alveolar proteinosis: a report of two cases.
Respiration
2001
0.75
26
Suppressive BALF lymphocyte phenotype in a patient with prolonged stable alveolar proteinosis.
Respiration
1998
0.75